NCT05678192View on ClinicalTrials.gov

Effect of Menopausal Hormone Therapy on Immune System Parameters

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions
Last Period Not Earlier Than 6 Months Ago
Interventions
DRUG

oral menopausal hormone therapy

Dydrogesterone 10 mg + Estradiol 1 mg/Dydrogesterone 5 mg + Estradiol 1 mg

DRUG

transdermal menopausal hormone therapy

Estradiol 1,5 mg + Progesterone 200 mg/Estradiol 1,5 mg + Progesterone 100 mg

Trial Locations (1)

117997

Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare, Moscow

All Listed Sponsors
lead

Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare

OTHER_GOV

NCT05678192 - Effect of Menopausal Hormone Therapy on Immune System Parameters | Biotech Hunter | Biotech Hunter